FDA Reorganizes at the Top, Taps Ex-Dartmouth Dean for Post (Wall Street Journal)
WASHINGTON—The Food and Drug Administration, whose relations with medical companies have been strained of late, named a former senior drug-company official and Dartmouth Medical School dean as its new deputy commissioner overseeing much of the agency's operations.
Commissioner Margaret A. Hamburg selected Stephen P. Spielberg to the new position of Deputy Commissioner for Medical Products and Tobacco. The appointment was part of a reorganization at the top of the nation's leading medical- and food-safety agency. Dr. Spielberg, a pediatrician and pharmacologist, most recently has served as director of personalized medicine at Children's Mercy Hospital in Kansas City.
Previously, he served as dean of Dartmouth Medical School and vice president for health affairs at Dartmouth College in Hanover, N.H. From 1997 to 2003, Dr. Spielberg was Johnson & Johnson's vice president for pediatric drug development and, prior to that, was at Merck & Co.'s research laboratories in senior positions. During that time he was chairman of the pediatric task force of PhRMA, the drug industry's trade association.
In a...
